Samira Sakhia

Supporting Desautels student leadership aspirations

Published: 30Aug2021

While leading a pharmaceutical company, Samira Sakhia (BCom’90, DPA’94, MBA’01) is also volunteering her expertise in the broader McGill community and supporting students in realizing their...

Samira Sakhia: Taking the helm at Knight Therapeutics and supporting Desautels student leadership aspirations

25 Aug 2021

Samira Sakhia, BCom’90, DPA’94, MBA’01, entered the BCom program as a self-described “numbers person” and naturally gravitated towards earning a Chartered Professional Accountant (CPA) designation...

Desautels alumna becomes President & CEO of Knight Therapeutics Inc.  

Published: 21May2021

Congratulations to Samira Sakhia (BCom’90, DPA’94, MBA’01), who will take on a new challenge as President and Chief Executive Officer of Knight Therapeutics Inc., a Montreal-based company focused...

Announcement of Knight Therapeutics CFO resignation

Published: 11Oct2017

Knight Therapeutics has announced the resignation of its chief financial officer, as the company’s president and Desautels International Faculty Advisory Board member, Samira Sakhia (BCom’90, DPA...

Samira Sakhia to present at investor conference

Published: 27Apr2017

At the Bloom Burton & Co Healthcare Investor Conference this May, Knight Therapeutics’ president, Samira Sakhia (BCom’90, DPA’94, MBA’01) will be giving the Montreal-based specialty...

Profound appoints Desautels alumna to its Board of Directors

Published: 8Mar2017

In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of Samira Sakhia (BCom’90, MBA’01) to its Board of Directors. Ms. Sakhia is also a member...

A Knight is Reborn

Published: 19Aug2016

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining...

People on the Move (October 2016 Update)

Published: 6Oct2016

Samira Sakhia, president of Knight Therapeutics, has joined Crescita Therapeutics Inc.’s board of directors.  Prior to her current role, she was the chief financial officer of Paladin Labs. She...

Nuvo Research® Announces Appointment to its Board of Directors

Published: 3Nov2015

Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced the...

Pages

Coronavirus (COVID-19)

Get the latest Covid-19 updates and learn what to expect for McGill’s return to campus this Fall, 2021.

For Desautels specific updates please visit our COVID-19 FAQ page.

Back to top